Anna Narezkina
Impact in
- Virology top 10%
- HIV Research and Treatment
-
- Viral Infections and Immunology Research
- Chemotherapy-induced cardiotoxicity and mitigation
- Cardiovascular Function and Risk Factors
Papers in
-
- Phosphodiesterase function and regulation 1
-
- Chemotherapy-induced cardiotoxicity and mitigation 1
- Co-authors
- Anna Marie Skalka (2 shared papers)Richard A. Katz (2 shared papers)Alice E. Zemljic‐Harpf (1 shared paper)Hari K. Narayan (1 shared paper)Christoph Seeger (1 shared paper)Samuel Litwin (1 shared paper)J. Hayashi (1 shared paper)Radka Stoyanova (1 shared paper)
- Journals
- Journal of Virology (2 papers)JCO Precision Oncology (1 paper)JACC Heart Failure (1 paper)Journal of Clinical Investigation (1 paper)Clinical Science (1 paper)
- Partner nations
- United StatesChinaSouth Korea
In The Last Decade
Anna Narezkina
14 papers receiving 350 citations
Peers
Comparison fields: 5 of 64
- Virology 48
- Cardiology and Cardiovascular Medicine 102
- Genetics 93
- Infectious Diseases 45
- Molecular Biology 162
Countries citing papers authored by Anna Narezkina
This map shows the geographic impact of Anna Narezkina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Narezkina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Narezkina more than expected).
Fields of papers citing papers by Anna Narezkina
This network shows the impact of papers produced by Anna Narezkina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Narezkina. The network helps show where Anna Narezkina may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Narezkina, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 130 | |
| 2 | 2021 | 50 | |
| 3 | 2013 | 39 | |
| 4 | 2011 | 35 | |
| 5 | 2007 | 30 | |
| 6 | 2021 | 29 | |
| 7 | 2021 | 13 | |
| 8 | 2022 | 12 | |
| 9 | 2021 | 11 | |
| 10 | 2021 | 2 | |
| 11 | 2020 | 2 | |
| 12 | 2022 | 2 | |
| 13 | 2024 | 1 | |
| 14 | 2024 | 1 |
About Anna Narezkina
Anna Narezkina is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine, Epidemiology and Genetics, having authored 14 papers that have together received 357 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Phosphodiesterase function and regulation (1 paper), Chemotherapy-induced cardiotoxicity and mitigation (1 paper), Neuroendocrine regulation and behavior (1 paper), Cancer-related cognitive impairment studies (1 paper), Cardiac Structural Anomalies and Repair (1 paper) and Advanced Breast Cancer Therapies (1 paper). The work is most often cited by research in Virology (48 citations), Cardiology and Cardiovascular Medicine (102 citations), Genetics (93 citations), Infectious Diseases (45 citations) and Molecular Biology (162 citations). Anna Narezkina has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Anna Marie Skalka, Richard A. Katz, Alice E. Zemljic‐Harpf, Hari K. Narayan, Christoph Seeger, Samuel Litwin, J. Hayashi, Radka Stoyanova, Konstantin D. Taganov and Kirk U. Knowlton. Their work appears in journals such as Journal of Virology, JCO Precision Oncology, JACC Heart Failure, Journal of Clinical Investigation and Clinical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.